Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.

OBJECTIVE: To evaluate the safety and efficacy of two intralesional doses of recombinant human interferon-beta (r-hIFN-beta: Rebif, Ares Serono), given 3 times a week for 3 weeks, in the treatment of condyloma acuminatum. DESIGN: A randomised, double-blind, within-patient, placebo-controlled study....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Monsonego, J, Cessot, G, Ince, S E, Galazka, A R, Abdul-Ahad, A K
Format: Artigo
Jezik:Inglês
Izdano: 1996
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1195619/
https://ncbi.nlm.nih.gov/pubmed/8698357
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki